{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:44:14Z","timestamp":1770331454519,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35320-z","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:05:44Z","timestamp":1767960344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel prognostic nomogram for elderly renal cell carcinoma patients with lung metastases"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhihui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"35320_CR1","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2021. CA. Cancer. J. Clin. 71, 7\u201333 (2021).","journal-title":"CA. Cancer. J. Clin."},{"key":"35320_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer. J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA. Cancer. J. Clin."},{"key":"35320_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40364-020-00195-3","volume":"8","author":"Z Du","year":"2020","unstructured":"Du, Z., Chen, W., Xia, Q., Shi, O. & Chen, Q. Trends and projections of kidney cancer incidence at the global and national levels, 1990\u20132030: a Bayesian age-period-cohort modeling study. Biomark Res. 8, 16 (2020).","journal-title":"Biomark Res."},{"key":"35320_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.270","volume":"11","author":"W Mao","year":"2021","unstructured":"Mao, W. et al. Sarcopenia as a poor prognostic indicator for renal cell carcinoma patients undergoing nephrectomy in China: A multicenter study. Clin. Transl. Med. 11, e270 (2021).","journal-title":"Clin. Transl. Med."},{"key":"35320_CR5","doi-asserted-by":"publisher","first-page":"1410450","DOI":"10.3389\/or.2024.1410450","volume":"18","author":"LN Le","year":"2024","unstructured":"Le, L. N., Munir, J., Kim, E. B. & Ryu, S. Kidney cancer and potential use of urinary extracellular vesicles. Oncol. Rev. 18, 1410450 (2024).","journal-title":"Oncol. Rev."},{"key":"35320_CR6","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3390\/cancers17030522","volume":"17","author":"N Shani Shrem","year":"2025","unstructured":"Shani Shrem, N. et al. Real-world efficacy and toxicity of ipilimumab and nivolumab as first-line treatment of metastatic renal cell carcinoma (mRCC) in a subpopulation of elderly and poor performance status patients. Cancers 17, 522 (2025).","journal-title":"Cancers"},{"key":"35320_CR7","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1158\/1078-0432.CCR-20-3868","volume":"27","author":"A Magnuson","year":"2021","unstructured":"Magnuson, A. et al. Modernizing clinical trial eligibility criteria: recommendations of the aSCO-friends of cancer research performance status work group. Clin. Cancer. Res. 27, 2424\u20132429 (2021).","journal-title":"Clin. Cancer. Res."},{"key":"35320_CR8","doi-asserted-by":"publisher","first-page":"723396","DOI":"10.3389\/fmed.2021.723396","volume":"8","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. The epidemiology of lung metastases. Front. Med. 8, 723396 (2021).","journal-title":"Front. Med."},{"key":"35320_CR9","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41588-019-0423-x","volume":"51","author":"Z Hu","year":"2019","unstructured":"Hu, Z. et al. Quantitative evidence for early metastatic seeding in colorectal cancer. Nat. Genet. 51, 1113\u20131122 (2019).","journal-title":"Nat. Genet."},{"key":"35320_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41572-025-00642-1","volume":"11","author":"L Zullo","year":"2025","unstructured":"Zullo, L. et al. Lung metastases. Nat. Rev. Dis. Primers. 11, 60 (2025).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"35320_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/pharmaceutics16010031","volume":"16","author":"T Nakamura","year":"2023","unstructured":"Nakamura, T., Sasaki, S., Sato, Y. & Harashima, H. Cancer immunotherapy with lipid nanoparticles loaded with a stimulator of interferon genes agonist against renal tumor lung metastasis. Pharmaceutics. 16, 31 (2023).","journal-title":"Pharmaceutics."},{"key":"35320_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/annonc\/mdr362","volume":"23","author":"M Bianchi","year":"2012","unstructured":"Bianchi, M. et al. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann. Oncol. 23, 973\u2013980 (2012).","journal-title":"Ann. Oncol."},{"key":"35320_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10238-025-01839-0","volume":"25","author":"Z Shang","year":"2025","unstructured":"Shang, Z., Tan, R., Wei, C., Hong, Z. & Ye, D. Development and external validation of a predictive model for lung metastases in kidney cancer based on clinical and laboratory features. Clin. Exp. Med. 25, 293 (2025).","journal-title":"Clin. Exp. Med."},{"key":"35320_CR14","doi-asserted-by":"publisher","first-page":"e29764","DOI":"10.1097\/MD.0000000000029764","volume":"101","author":"Z Lu","year":"2022","unstructured":"Lu, Z., Yang, C., He, W., Zhou, J. & Xiang, R. Nomogram to predict risk and prognosis of synchronous lung metastasis in renal cell carcinoma: A large cohort analysis. Medicine 101, e29764 (2022).","journal-title":"Medicine"},{"key":"35320_CR15","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Liang, C., Hou, B. & Zhou, L. 2021 Population-based evaluation of the risk factors and prognosis among renal cell carcinoma patients with initially diagnosed lung metastases. Actas. Uro.l Esp. 45, 498\u2013506","DOI":"10.1016\/j.acuroe.2021.06.004"},{"key":"35320_CR16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.omtn.2020.08.022","volume":"22","author":"Y Bi","year":"2020","unstructured":"Bi, Y. et al. An interpretable prediction model for identifying N (7)-methylguanosine sites based on XGBoost and SHAP. Mol. Ther. Nucleic. Acids. 22, 362\u2013372 (2020).","journal-title":"Mol. Ther. Nucleic. Acids."},{"key":"35320_CR17","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA. Cancer. J. Clin. 70, 7\u201330 (2020).","journal-title":"CA. Cancer. J. Clin."},{"key":"35320_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1477-7819-5-16","volume":"5","author":"S Denzinger","year":"2007","unstructured":"Denzinger, S. et al. Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?. World. J. Surg. Oncol. 5, 16 (2007).","journal-title":"World. J. Surg. Oncol."},{"key":"35320_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.15256\/joc.2011.1.4","volume":"1","author":"A Nobili","year":"2011","unstructured":"Nobili, A., Garattini, S. & Mannucci, P. M. Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium. J. Comorb. 1, 28\u201344 (2011).","journal-title":"J. Comorb."},{"key":"35320_CR20","doi-asserted-by":"publisher","first-page":"6627562","DOI":"10.1155\/2021\/6627562","volume":"2021","author":"X Sheng","year":"2021","unstructured":"Sheng, X., Lu, X., Wu, J., Chen, L. & Cao, H. A nomogram predicting the prognosis of renal cell carcinoma patients with lung metastases. Biomed. Res. Int. 2021, 6627562 (2021).","journal-title":"Biomed. Res. Int."},{"key":"35320_CR21","doi-asserted-by":"publisher","first-page":"1572580","DOI":"10.3389\/fimmu.2025.1572580","volume":"16","author":"F Wang","year":"2025","unstructured":"Wang, F. et al. A novel nomogram for survival prediction in renal cell carcinoma patients with brain metastases: An analysis of the SEER database. Front. Immunol. 16, 1572580 (2025).","journal-title":"Front. Immunol."},{"key":"35320_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch, H., Cubilla, A. L., Humphrey, P. A., Reuter, V. E. & Ulbright, T. M. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: Renal, penile, and testicular tumours. Eur. Urol. 70, 93\u2013105 (2016).","journal-title":"Eur. Urol."},{"key":"35320_CR23","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMoa003013","volume":"345","author":"RC Flanigan","year":"2001","unstructured":"Flanigan, R. C. et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N. Engl. J. Med. 345, 1655\u20131659 (2001).","journal-title":"N. Engl. J. Med."},{"key":"35320_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2018.09.016","volume":"75","author":"B Bhindi","year":"2019","unstructured":"Bhindi, B. et al. Systematic review of the role of cytoreductive nephrectomy in the targeted therapy era and beyond: An individualized approach to metastatic renal cell carcinoma. Eur. Urol. 75, 111\u2013128 (2019).","journal-title":"Eur. Urol."},{"key":"35320_CR25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.eururo.2020.04.038","volume":"78","author":"B Bhindi","year":"2020","unstructured":"Bhindi, B. et al. Deferred cytoreductive nephrectomy in patients with newly diagnosed metastatic renal cell carcinoma. Eur. Urol. 78, 615\u2013623 (2020).","journal-title":"Eur. Urol."},{"key":"35320_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.euo.2023.10.002","volume":"7","author":"K Takemura","year":"2024","unstructured":"Takemura, K. et al. Characterization of patients with metastatic renal cell carcinoma undergoing deferred, upfront, or no cytoreductive nephrectomy in the era of combination immunotherapy: Results from the international metastatic renal cell carcinoma database consortium. Eur. Urol. Oncol. 7, 501\u2013508 (2024).","journal-title":"Eur. Urol. Oncol."},{"key":"35320_CR27","doi-asserted-by":"publisher","first-page":"9657","DOI":"10.1007\/s00432-023-04885-x","volume":"149","author":"Z Luo","year":"2023","unstructured":"Luo, Z. et al. Do patients with metastatic renal cell carcinoma obtain survival benefits from cytoreductive nephrectomy? A population-based study. J. Cancer. Res. Clin. Oncol. 149, 9657\u20139670 (2023).","journal-title":"J. Cancer. Res. Clin. Oncol."},{"key":"35320_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1803675","volume":"379","author":"A M\u00e9jean","year":"2018","unstructured":"M\u00e9jean, A. et al. Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma. N. Engl. J. Med. 379, 417\u2013427 (2018).","journal-title":"N. Engl. J. Med."},{"key":"35320_CR29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jamaoncol.2018.5543","volume":"5","author":"A Bex","year":"2019","unstructured":"Bex, A. et al. Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: The SURTIME randomized clinical trial. JAMA. Oncol. 5, 164\u2013170 (2019).","journal-title":"JAMA. Oncol."},{"key":"35320_CR30","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1038\/s41598-024-54085-x","volume":"14","author":"L Jiang","year":"2024","unstructured":"Jiang, L. et al. A dynamic visualization clinical tool constructed and validated based on the SEER database for screening the optimal surgical candidates for bone metastasis in primary kidney cancer. Sci. Rep. 14, 3561 (2024).","journal-title":"Sci. Rep."},{"key":"35320_CR31","first-page":"229","volume":"21","author":"B Guo","year":"2021","unstructured":"Guo, B., Liu, S., Wang, M., Hou, H. & Liu, M. The role of cytoreductive nephrectomy in renal cell carcinoma patients with liver metastasis. Bosn. J. Basic. Med. Sci. 21, 229\u2013234 (2021).","journal-title":"Bosn. J. Basic. Med. Sci."},{"key":"35320_CR32","doi-asserted-by":"publisher","first-page":"1464589","DOI":"10.3389\/fmed.2024.1464589","volume":"11","author":"F Wang","year":"2024","unstructured":"Wang, F. et al. Development and validation of a prediction model for the prognosis of renal cell carcinoma with liver metastases: A population-based cohort study. Front. Med. 11, 1464589 (2024).","journal-title":"Front. Med."},{"key":"35320_CR33","doi-asserted-by":"crossref","unstructured":"Nepali, P. R. et al. Molecular and therapeutic landscape of non-clear cell renal carcinoma. Nat. Rev. Urol. (2025).","DOI":"10.1038\/s41585-025-01056-0"},{"key":"35320_CR34","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.3390\/cancers13153807","volume":"13","author":"P Sepe","year":"2021","unstructured":"Sepe, P. et al. Characteristics and treatment challenges of non-clear cell renal cell carcinoma. Cancers 13, 3807 (2021).","journal-title":"Cancers"},{"key":"35320_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.breast.2016.12.008","volume":"32","author":"L Hinyard","year":"2017","unstructured":"Hinyard, L., Wirth, L. S., Clancy, J. M. & Schwartz, T. The effect of marital status on breast cancer-related outcomes in women under 65: A SEER database analysis. Breast 32, 13\u201317 (2017).","journal-title":"Breast"},{"key":"35320_CR36","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s10654-021-00781-1","volume":"36","author":"C Salmon","year":"2021","unstructured":"Salmon, C. et al. Marital status and prostate cancer incidence: A pooled analysis of 12 case-control studies from the PRACTICAL consortium. Eur. J. Epidemiol. 36, 913\u2013925 (2021).","journal-title":"Eur. J. Epidemiol."},{"key":"35320_CR37","doi-asserted-by":"publisher","first-page":"6638","DOI":"10.12659\/MSM.911673","volume":"24","author":"Z Gao","year":"2018","unstructured":"Gao, Z. et al. Marital status and survival of patients with chondrosarcoma: A population-based analysis. Med. Sci. Monit. 24, 6638\u20136648 (2018).","journal-title":"Med. Sci. Monit."},{"key":"35320_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.oraloncology.2018.12.009","volume":"89","author":"MC Simpson","year":"2019","unstructured":"Simpson, M. C. et al. Impact of gender on the association between marital status and head and neck cancer outcomes. Oral. Oncol. 89, 48\u201355 (2019).","journal-title":"Oral. Oncol."},{"issue":"1","key":"35320_CR39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.eururo.2016.03.011","volume":"70","author":"R Montironi","year":"2016","unstructured":"Montironi, R., Cheng, L., Scarpelli, M. & Lopez-Beltran, A. Pathology and genetics tumours of the urinary system and male genital system: Clinical implications of the 4th edition of the WHO classification and beyond. Eur. Urol. 70(1), 120\u2013123 (2016).","journal-title":"Eur. Urol."},{"key":"35320_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev-bioeng-062117-120947","volume":"20","author":"E Lin","year":"2018","unstructured":"Lin, E., Cao, T., Nagrath, S. & King, M. R. Circulating tumor cells: Diagnostic and therapeutic applications. Annu. Rev. Biomed. Eng. 20, 329\u2013352 (2018).","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"35320_CR41","doi-asserted-by":"publisher","first-page":"1127625","DOI":"10.3389\/fmed.2023.1127625","volume":"10","author":"L Jiang","year":"2023","unstructured":"Jiang, L., Tong, Y., Jiang, J. & Zhao, D. Individualized assessment predictive models for risk and overall survival in elderly patients of primary kidney cancer with bone metastases: A large population-based study. Front. Med. 10, 1127625 (2023).","journal-title":"Front. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35320-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35320-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35320-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:17:48Z","timestamp":1770286668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35320-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35320"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35320-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval for this study was granted by the relevant ethics review committee. The data utilized were obtained from the publicly available SEER database, for which patient informed consent had been secured during its original compilation. The entire study was conducted in adherence to all applicable local regulations and institutional guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"4955"}}